Literature DB >> 13860583

Immunity against tularemia: passive protection of mice by transfer of immune tissues.

W P ALLEN.   

Abstract

Acquired resistance to fully virulent strains of P. tularensis was passively transferred to normal mice by viable spleen cells or peritoneal leucocytes from donors that recovered from infection with an attenuated strain of P. tularensis. This passively transferred resistance was reflected in survival or delayed death after challenge of the recipients. The degree of passively transferred resistance was dependent upon the immune status of the donors and the number of viable immune cells transferred. There were indications that this resistance persisted only as long as the transferred tissues were compatible with the tissues of the recipient. The results support the hypothesis that immunity of mice against fully virulent strains of P. tularensis is associated with an altered state of the tissues.

Entities:  

Keywords:  TULAREMIA/immunology

Mesh:

Year:  1962        PMID: 13860583      PMCID: PMC2137492          DOI: 10.1084/jem.115.2.411

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

Authors:  H T EIGELSBACH; C M DOWNS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

2.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

3.  Passive transfer of resistance to tuberculosis through use of monocytes.

Authors:  J L SEVER
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

4.  Intracellular multiplication of Brucella abortus in normal and immune mononuclear phagocytes.

Authors:  A POMALES-LEBRON; W R STINEBRING
Journal:  Proc Soc Exp Biol Med       Date:  1957-01

5.  New medium for the cultivation of Pasteurella tularensis.

Authors:  W D WON
Journal:  J Bacteriol       Date:  1958-02       Impact factor: 3.490

6.  Studies on the pathogenesis and immunity of tularemia. I. The demonstration of a protective antibody in mouse serum.

Authors:  L PANNELL; C M DOWNS
Journal:  J Infect Dis       Date:  1953 Mar-Apr       Impact factor: 5.226

7.  ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT.

Authors:  L Foshay; I Ruchman; P S Nicholes
Journal:  J Clin Invest       Date:  1947-07       Impact factor: 14.808

8.  Hemagglutination by tularemia antisera: further observations on agglutination of polysaccharide-treated erythrocytes and its inhibition by polysaccharide.

Authors:  G G WRIGHT; R J FEINBERG
Journal:  J Immunol       Date:  1952-01       Impact factor: 5.422

9.  Studies on chemotherapy of vaccinia virus. I. An experimental design for testing antiviral agents.

Authors:  K A BROWNLEE; D HAMRE
Journal:  J Bacteriol       Date:  1951-02       Impact factor: 3.490

10.  A cellular basis of immunity in experimental Brucella infection.

Authors:  J J HOLLAND; M J PICKETT
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains.

Authors:  Gopi Mara-Koosham; Julie A Hutt; C Rick Lyons; Terry H Wu
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

3.  Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; D Sharma; M Solotorovsky; R Lafemina; J Balint
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

5.  Protection against dysentery infection (Shigella sonnei) by cells of peritoneal exudate, spleen, thymus, bone marrow and mesenteric lymph nodes of non-immune and specifically immunized mice.

Authors:  N B Kamzolkina
Journal:  Folia Microbiol (Praha)       Date:  1974       Impact factor: 2.099

6.  Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S E Holm
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

7.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

8.  Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

Authors:  T R Rhinehart-Jones; A H Fortier; K L Elkins
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Isolation of Francisella tularensis from infected frozen human blood.

Authors:  B Pittman; E B Shaw; W B Cherry
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

10.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.